Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HIV-1 protease inhibitors(HIV protease inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H52N2O5 |
InChIKeyMBNPLZRTGOAFGX-UHFFFAOYSA-N |
CAS Registry162054-18-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Preclinical | US | - | |
HIV Infections | Preclinical | - | - |